Review-State-Aware Comparison
Amazonian Cinnamon vs Black Caraway Seed
An automated side-by-side view of two public profiles. It has not been individually curated as a clinical comparison and is excluded from search indexing. Scores and narratives are provisional unless a profile explicitly states human approval; no personal dosage or combination conclusion is provided.
This page cannot establish which ingredient is better, whether either is effective, or whether they can be combined safely. Editorial and quality-gate review approved this evidence record. Editorial and quality-gate review approved this evidence record.
Amazonian Cinnamon
Human-reviewed public score: 10/10
Black Caraway Seed
Human-reviewed public score: 10/10Human-Reviewed Benefit Text
Amazonian Cinnamon
Black Caraway Seed
Human-Reviewed Mechanism Text
Trans-cinnamaldehyde, the primary bioactive compound in Amazonian Cinnamon bark, suppresses the NF-κB and AP-1 transcription factor pathways by inhibiting IκB kinase (IKK) phosphorylation, thereby reducing expression of pro-inflammatory cytokines including TNF-α, IL-1β, and IL-6. Simultaneously, cinnamaldehyde activates the Keap1-Nrf2-ARE signaling axis, upregulating phase II detoxification enzymes such as heme oxygenase-1 (HO-1), NAD(P)H quinone oxidoreductase 1 (NQO1), and glutathione S-transferase (GST), conferring potent antioxidant cytoprotection. Regarding glucose metabolism, cinnamaldehyde enhances insulin receptor substrate-1 (IRS-1) phosphorylation and stimulates GLUT4 translocation to the cell membrane in skeletal muscle and adipose tissue, improving peripheral glucose uptake. Additional constituents including methyl cinnamate and polyphenolic proanthocyanidins contribute to α-glucosidase and α-amylase inhibition, delaying carbohydrate digestion and postprandial glycemic spikes.
Thymoquinone, the principal bioactive constituent (30–48% of Nigella sativa essential oil), exerts anti-inflammatory effects primarily by inhibiting the NF-κB signaling cascade, thereby downregulating transcription of pro-inflammatory cytokines TNF-α, IL-6, and IL-1β, as well as suppressing cyclooxygenase-2 (COX-2), inducible nitric oxide synthase (iNOS), and matrix metalloproteinases (MMPs) (PMID 34073784; PMID 39769174). Its antioxidant mechanism involves direct scavenging of superoxide anions and hydroxyl radicals, upregulation of endogenous antioxidant enzymes including superoxide dismutase (SOD), catalase, and glutathione peroxidase (GPx), and preservation of intracellular glutathione (GSH) levels through Nrf2 pathway activation (PMID 39807848). Thymoquinone also modulates the PI3K/Akt/mTOR and MAPK/ERK pathways, contributing to its antiproliferative and pro-apoptotic effects in cancer cell lines, while simultaneously activating AMPK signaling to improve insulin sensitivity and hepatic glucose metabolism (PMID 34073784; PMID 24111621). Additional bioactive components—thymohydroquinone, thymol, carvacrol, and α-hederin—contribute synergistically to antimicrobial activity by disrupting bacterial cell membrane integrity (PMID 23646296).
Human-Reviewed Safety Text
Amazonian Cinnamon bark contains coumarin at lower levels than Cinnamomum cassia, but prolonged high-dose consumption may still pose hepatotoxicity risk in sensitive individuals; the European Food Safety Authority (EFSA) established a tolerable daily intake of 0.1 mg coumarin per kg body weight. Cinnamaldehyde-rich preparations may potentiate the effects of antidiabetic medications (metformin, sulfonylureas, insulin), increasing hypoglycemia risk, and may enhance anticoagulant activity of warfarin and other blood thinners due to mild antiplatelet properties. In vitro evidence suggests cinnamaldehyde can inhibit CYP2A6 and CYP2E1 enzymes, potentially altering metabolism of substrates processed by these isoforms; individuals on medications metabolized by these pathways should consult a healthcare provider. Pregnant and breastfeeding women should avoid therapeutic doses due to insufficient safety data, and individuals with liver disease should exercise caution.
Nigella sativa is generally recognized as safe at culinary doses (1–3 g seed/day) and supplemental doses up to 2–3 g/day or 200–600 mg thymoquinone-standardized oil for up to 12 weeks in clinical trials, though higher doses have been associated with gastrointestinal discomfort, nausea, and contact dermatitis in sensitive individuals (PMID 30000936; PMID 34073784). Thymoquinone has demonstrated inhibition of CYP3A4 and CYP2D6 in preclinical models, raising the potential for interactions with substrates of these enzymes including cyclosporine, warfarin, and certain antihypertensive and antidiabetic medications—concurrent use may potentiate hypoglycemic or hypotensive effects (PMID 39769174; PMID 30000936). Pregnant and breastfeeding women should avoid therapeutic doses, as uterotonic effects have been observed in animal studies; individuals scheduled for surgery should discontinue use at least two weeks prior due to potential antiplatelet activity (PMID 34073784). Hepatotoxicity has been reported in rare cases at very high doses, and liver function should be monitored during prolonged high-dose supplementation (PMID 30000936).
Comparison summary
This automated view does not establish that either Amazonian Cinnamon or Black Caraway Seed is effective, superior, suitable, or safe to combine. Both have the same provisional public score (10/10). This ordering does not establish clinical superiority, safety, or suitability. Use the linked profiles and a qualified healthcare professional for decisions.
Frequently Asked Questions
Is Amazonian Cinnamon or Black Caraway Seed better?
Amazonian Cinnamon and Black Caraway Seed have the same provisional public score (10/10). A score tie does not establish equivalent evidence or outcomes.
Can you take Amazonian Cinnamon and Black Caraway Seed together?
No reviewed combination conclusion is established by this comparison. A missing reviewed interaction record means unknown, not safe. Consult a qualified healthcare professional before combining supplements.
What is the main difference between Amazonian Cinnamon and Black Caraway Seed?
Amazonian Cinnamon is categorized as bark (Compound), while Black Caraway Seed is categorized as seed (Compound). Category labels are classification fields, not evidence of benefit; claim-bearing text appears only when both profiles have recorded human approval.
These statements have not been evaluated by the Food and Drug Administration. This content is for informational purposes only and is not intended to diagnose, treat, cure, or prevent any disease.